FDA Approved: SMOFLIPID — Supplemental Application (Fresenius Kabi USA, LLC)

View source ↗

Summary

The FDA approved a supplemental application for SMOFLIPID submitted by Fresenius Kabi USA, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Fatty Acid Deficiency
• Malnutrition

Drugs mentioned

• SMOFLIPID

Snippet

SUPPL AP for SMOFLIPID (SMOFLIPID)